CIK 0001326190
- Non-accelerated filer
- Smaller reporting company
Altimmune, Inc.
Sign in to watch- Ticker
- ALT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 202726770
- Phone
- +1 862-457-1450
- Business address
- 350 MOUNT KEMBLE AVENUE, SUITE 1001, MORRISTOWN, NJ, 07960
- Former names
- PHARMATHENE, INC, HEALTHCARE ACQUISITION CORP
- Open-market buys, last 90 days
- $82,244
- in 3 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$82,244. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-31 | Roberts M Scot Chief Scientific Officer | Grant or award | +875 | $2.41 | $2K | 113,699 |
| 2026-02-26 | Roberts M Scot Chief Scientific Officer | Grant or award · Stock Options (option to buy) | +222,670 | 222,670 | ||
| 2026-02-26 | Roberts M Scot Chief Scientific Officer | Grant or award · Restricted Stock Units | +95,430 | 95,430 | ||
| 2026-02-02 | Roberts M Scot Chief Scientific Officer | Option exercise | +7,775 | 115,153 | ||
| 2026-02-02 | Roberts M Scot Chief Scientific Officer | Shares withheld for taxes | −2,329 | $5.55 | $13K | 112,824 |
| 2026-02-02 | Roberts M Scot Chief Scientific Officer | Option exercise · Restricted Stock Units | −7,775 | 0 | ||
| 2026-01-31 | Roberts M Scot Chief Scientific Officer | Grant or award | +5,567 | $3.07 | $17K | 107,378 |
| 2026-01-30 | Roberts M Scot Chief Scientific Officer | Option exercise | +9,275 | 104,670 | ||
| 2026-01-30 | Roberts M Scot Chief Scientific Officer | Shares withheld for taxes | −2,859 | $5.60 | $16K | 101,811 |
| 2026-01-30 | Roberts M Scot Chief Scientific Officer | Option exercise · Restricted Stock Units | −9,275 | 9,275 | ||
| 2026-01-27 | Roberts M Scot Chief Scientific Officer | Option exercise | +15,850 | 100,143 | ||
| 2026-01-27 | Roberts M Scot Chief Scientific Officer | Shares withheld for taxes | −4,748 | $6.18 | $29K | 95,395 |
| 2026-01-27 | Roberts M Scot Chief Scientific Officer | Option exercise · Restricted Stock Units | −15,850 | 47,550 | ||
| 2026-01-25 | Roberts M Scot Chief Scientific Officer | Option exercise | +14,600 | 88,666 | ||
| 2026-01-25 | Roberts M Scot Chief Scientific Officer | Shares withheld for taxes | −4,373 | $5.50 | $24K | 84,293 |
| 2026-01-25 | Roberts M Scot Chief Scientific Officer | Option exercise · Restricted Stock Units | −14,600 | 29,200 | ||
| 2025-07-31 | Roberts M Scot Chief Scientific Officer | Grant or award | +846 | $3.14 | $3K | 74,066 |
| 2025-02-02 | Roberts M Scot Chief Scientific Officer | Option exercise | +7,775 | 75,536 | ||
| 2025-02-02 | Roberts M Scot Chief Scientific Officer | Shares withheld for taxes | −2,316 | $6.64 | $15K | 73,220 |
| 2025-02-02 | Roberts M Scot Chief Scientific Officer | Option exercise · Restricted Stock Units | +7,775 | 7,775 |
Page 1 of 5 · 96 trades